Berardinelli-Seip congenital lipodystrophy 2 mRNA 3' untranslated region (BSCL2 mRNA 3'UTR) (BSCL2 mRNA 3'UTR)

The BSCL2 mRNA 3' untranslated region (3'UTR) is a key regulatory segment of the transcript encoding Seipin, a protein essential for lipid droplet biogenesis (UniProt Q8WUX1). Seipin is primarily localized in the endoplasmic reticulum, where it facilitates the budding of lipid droplets and maintains lipid homeostasis (PMID: 21730171). The 3'UTR of the BSCL2 mRNA contains specific sequences that serve as binding sites for microRNAs, such as miR-125b, which negatively regulate Seipin expression (PMID: 30563845). Mutations in the BSCL2 gene are the primary cause of Berardinelli-Seip congenital lipodystrophy type 2, a condition characterized by a lack of functional adipose tissue and severe insulin resistance (NCBI Gene: 11315). Additionally, certain gain-of-function mutations in BSCL2 lead to seipinopathies, a group of motor neuron diseases including Silver syndrome (PMID: 22431511). Targeting the 3'UTR allows for the modulation of Seipin protein levels without altering the genomic DNA, providing a potential therapeutic avenue for metabolic and neurological disorders. Experimental approaches using antisense oligonucleotides (ASOs) or microRNA modulators are being explored to either enhance or suppress Seipin production. This target is particularly relevant for biotech research focused on RNA-based therapeutics for rare genetic diseases and metabolic syndrome.

Other names

Seipin mRNA 3'UTRBSCL2 3'UTRGNG3LG mRNA 3'UTRHMN5 mRNA 3'UTRSPG17 mRNA 3'UTR

Modulation of protein expression by targeting regulatory elements within the 3' untranslated region to alter mRNA stability or translation efficiency.